Member list of California Life Sciences Association

Below you find a list of all members of CLSA in alphabetical order.

Results 721 - 740 out of 950 displayed.
 
Sort direction:
Sort direction:
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36 37  38  39  40  41  42  43  44  45  46  47  48 »
Rain Oncology Inc.   
Newark, USA
Rain Therapeutics Inc. is a biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53.
Rakuten Medical, Inc.   
San Diego, USA
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform, which, in pre-clinical studies, has been shown to induce rapid and selective cell killing and tumor necrosis.
Raydiant Oximetry, Inc.   
San Ramon, USA
Raydiant Oximetry is a company developing a fetal monitoring device. The company offers a non-invasive biomedical device to monitor the oxygen levels in fetal blood during childbirth. The device is designed to help clinicians reduce the risk of birth injury and over-intervention as well as decrease cesarean delivery rates.
RayzeBio, Inc.   
San Diego, USA
RayzeBio is building a vertically integrated radiopharmaceutical therapeutics (RPT) company to treat various cancers, with its lead program in a Phase 3 clinical trial. RayzeBio has created a pipeline of multiple drug candidates in therapeutic areas with significant market opportunities.
Reactive Medical Labs Inc.   
Davis, USA
Reactive Medical Labs is a biotechnology company developing regenerative skincare applications. The company aims to improve the penetration of agents across the skin barrier for common and visible skin conditions. The company develops proprietary topical aesthetic and therapeutic prescription-strength skin care systems to isolate pure and potent MSC-derivedExosomes, enabling healthcare institutions to solve the unmet needs of skincare aging.
ReadCube   
Cambridge, USA
ReadCube is a technology company that develops reference management software. The company's literature management system helps businesses discover, organize, review, read, annotate, share, and cite research, and make research more accessible and connected - serving researchers, publishers, academic and commercial organizations.
ReCor Medical, Inc.   
Palo Alto, USA
ReCor Medical, Inc. is a medical technology company focused on transforming the management of hypertension. The company has pioneered the use of the Paradise Ultrasound Renal Denervation (uRDN) System for the treatment of hypertension. The Paradise Renal Denervation System is a minimally invasive procedure to treat overactive nerves leading to the kidney.
Refined Processes, LLC   
Solana Beach, USA
Refined Processes, LLC is a Service Provider, including CROs/CMOs. Refined Process describes itself as a “business-minded product development team” focusing on custom software development, business science, and product development.
Regel Therapeutics Inc.   
Cambridge, USA
Regel Therapeutics develops precision genetic medicines for severe genetic diseases using a proprietary Targeted EpiEditing platform. The technology combines a deactivated version of CRISPR-Cas9 fused with an epigenetic modulator to correct abnormal gene expression without altering the underlying DNA sequence. Interventions are delivered via adeno-associated virus (AAV) vectors equipped with proprietary regulatory elements designed to restrict therapeutic activity exclusively to the specific...
Regencor, Inc.   
San Carlos, USA
Regencor is a regenerative medicine company dedicated to developing cardiac regenerative therapies aimed at treating myocardial infarction and heart failure. The company is advancing two distinct formulations of its proprietary active pharmaceutical ingredient (API), non-glycosylated rhFSTL1, to facilitate the direct delivery of this regenerative protein to the human heart during Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG) procedures.
Regenerative Arthritis & Bone Medicine, Inc.   
Burlingame, USA
Regenerative Arthritis & Bone Medicine, Inc. (RABOME) is a biotechnology research and development company focused on advancing innovative therapies for musculoskeletal diseases and bone regeneration. The company is developing novel treatments for conditions such as osteonecrosis, fracture healing, osteoporosis, and inflammatory arthritis. Its lead therapeutic candidate, RAB-001 (LLP2A-Ale), is designed to enhance bone repair by targeting mesenchymal stem cells (MSCs) to bone surfaces through...
Rejuvenate Bio   
San Diego, USA
Rejuvenate Bio is a biotechnology company dedicated to developing novel gene therapies for chronic age-related diseases. The company is focused on reversing aging and eliminating age-related disease. The company utilizes gene therapy, proprietary targets, and tools to bring treatments to patients suffering from age-related conditions. The company is developing a pipeline of therapies with applications in cardiac and metabolic disease.
Rejuvenation Technologies Inc.   
Mountain View, USA
Rejuvenation Technologies Inc. is a developer of a telomere extender designed to reverse the effect of telomere shortening. The company's nucleoside-modified mRNA encodes telomerase reverse transcriptase which is delivered to cells to transiently increase telomerase activity for extending telomeres which increase the proliferative capacity of cells, enabling patients to slow down age-related diseases and conditions. The company's current disease areas are pulmonary fibrosis (COPD), liver cirrhosis,...
RemeGen BioSciences   
South San Francisco, USA
RemeGen Biosciences is a biotechnology company which is focused on developing treatments for autoimmune, oncology and ophthalmic diseases. The company's products include Telitacicept, Disitamab Vedotin, etc.
Resilient Biotics, Inc   
Durham, USA
Reslient Biotics is a company developing microbiome-based live biotherapeutics for respiratory diseases in animal and human health. The company uses proprietary microbiome genomics, machine learning, data analytics and targeted laboratory assays to identify naturally occurring microbial strains with pathogen-inhibiting and immune-activating properties. The company's development programs focus on non-antibiotic approaches to prevent or reduce complex respiratory infections, including bovine and...
Revance Therapeutics, Inc.   
Nashville, USA
Revance Therapeutics is a prominent biotechnology and medical aesthetics company. The company specializes in the development, manufacturing, and commercialisation of botulinum toxin products, premium skincare, and dermal fillers. DAXXIFY® (DaxibotulinumtoxinA-lanm) is the company's flagship neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients...
Revel Pharmaceuticals, Inc.   
San Francisco, USA
Revel Pharmaceuticals develops targeted therapeutic enzymes to clear molecular damage in the extracellular matrix (ECM). By targeting advanced glycation end-products (AGEs) like glucosepane crosslinks, their platform aims to restore tissue elasticity, lower blood pressure, and reverse age-related ECM stiffening.
Revelation Biosciences Inc.   
San Diego, USA
Revelation Biosciences, Inc. is a clinical-stage biotechnology company focused on the development of immunomodulatory therapeutics targeting dysregulated inflammation. The company’s proprietary platform is based on phosphorylated hexaacyl disaccharide (PHAD®), a synthetic Toll-like receptor 4 (TLR4) agonist designed to prime and rebalance the innate immune response. Its lead candidate, Gemini, is being evaluated for the prevention and treatment of acute and chronic inflammatory conditions,...
RevMAb Biosciences USA, Inc.   
Burlingame, USA
RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of recombinant monoclonal antibodies using a technology that does not require cell fusion and hybridoma generation. The company's mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis.
Revolution Medicines, Inc.   
Redwood City, USA
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON)...

«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36 37  38  39  40  41  42  43  44  45  46  47  48 »

Disclaimer: Any membership totals displayed reflect organizations who have agreed to display their membership information and may not be indicative of CLSA's total member population.

© Biotechgate by Venture Valuation